The frequent exclusion of such patients from trials makes real-world data like these valuable for clinicians, says Eric ...

The study isn’t intended to sway clinical decision-making, but to make doctors aware of the impact of their choices.

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

The BaxHTN study met its primary endpoint, and researchers will present more data at the ESC Congress later this summer.

Both ablation and various lifestyle modifications, like losing weight and exercising more, have roles to play, experts agree.

The US Food and Drug Administration has approved the use of finerenone (Kerendia) in heart failure (HF) patients with mildly ...

Using OCT to look at the burden, not just individual factors, helps provide clues on why disease develops—and how it ...

Trends point to more and more PCIs being performed via the wrist, but the US still trails behind other countries.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

The CAC-DAD score will need to be externally validated in lower risk patients before it can be used clinically, several ...

It may be that patients have better control of cerebrovascular risk factors after the event, protecting against future ...

Patients with abnormal findings had worse outcomes down the road. Still unknown is exactly how to modify that risk.